跳至主要内容
临床试验/NCT00971061
NCT00971061已完成3 期

Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma

Vanak Eye Surgery Center1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2003年1月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
72
试验地点
1
主要终点
Intra Ocular pressure (IOP)

研究概览

简要总结

The purpose of this study is to investigate the efficacy and safety of the Ahmed valve implant (AVI) and the Molteno single-plate implant (MSPI) in eyes with refractory glaucoma during a follow-up period of 24 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • refractory glaucoma, defined as uncontrolled IOP despite maximal anti-glaucoma medication, previously failed nonseton surgical treatment, or a combination thereof.

排除标准

  • age less than 40 years
  • a visual acuity of no light perception
  • lens opacity
  • elevated IOP associated with silicone oil previous glaucoma drainage device implantation in the same eye
  • previous cyclodestructive treatment
  • increased risk of endophthalmitis posterior segment disorders
  • pre-existing ocular comorbidities.

结局指标

主要结局

Intra Ocular pressure (IOP)

时间窗: Month 24

次要结局

  • Intra Ocular pressure (IOP)(day 1,week 1, and months 1, 3, 6, 9, 12 and 18)
  • Changes in visual acuity(day 1,week 1, and months 1, 3, 6, 9, 12, 18, and 24.)
  • Number of anti-glaucoma medications(week 1, and months 1, 3, 6, 9, 12, 18, and 24)
  • Mean deviation of visual field,(week 1, and months 1, 3, 6, 9, 12, 18, and 24)
  • Rate of intra- and postoperative complications(week 1, and months 1, 3, 6, 9, 12, 18, and 24)

研究者

发起方
Vanak Eye Surgery Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验